Do you ever wonder why you’re so strongly motivated to exercise while it seems that some others inexplicably aren’t? The answer may lie in the differences between your gut microbiomes! Nature, the world’s leading multidisciplinary science journal, recently published the results of a study...
Source: FPWR Blog
|
Published: March 3 2023 - 08:29 AM
![PWS Registry Data: Mental Health Therapies [INFOGRAPHIC]](https://www.fpwr.org/hubfs/Therapies%20%202023%20Registry%20Infographic%20%281%29-2.png)
As a rare disorder, PWS is most well-known to the medical community and general population for hyperphagia, or intense food-seeking behavior. However, family members, caregivers, and individuals with PWS know that behavior difficulties and mental health can often impact quality of life as much, or...
Source: FPWR Blog
|
Published: March 3 2023 - 08:53 AM
FPWR is investigating several devices that have been proven effective in treating a myriad of symptoms associated with other medical conditions & have considerable potential to relieve symptoms of PWS. Devices offer many advantages including an expedited timeline from proof-of-concept to patient...
Source: FPWR Blog
|
Published: February 2 2023 - 12:10 PM
UPDATE, FEBRUARY 2023: FPWR is preparing to launch our VNS4PWS clinical trial. Details of the study protocol are currently being finalized and we are beginning discussions with potential trial sites. We plan to begin enrolling volunteers mid-2023. Recent evidence from FPWR-supported studies show...
Source: FPWR Blog
|
Published: February 2 2023 - 07:45 AM
You’re probably seen at least one headline heralding the remarkable successes of Novo Nordisk’s drug Wegovy (Semaglutide, 2.4 mg) and Eli Lily’s tirzepatide (currently only approved for type 2 diabetes – likely to be approved for weight loss later this year), for the treatment of obesity.
Source: FPWR Blog
|
Published: February 2 2023 - 09:00 AM
